Superpatents Spark Debate Over IP Issues

Law360, New York (May 5, 2006, 12:00 AM EDT) -- With the advent of global health crises such as HIV/AIDS, global trading rules have been amended in recent years to provide poor countries with the right to break drug patents and produce cheap generic drugs.

However, U.S. trade negotiators, concerned with protecting the intellectual property rights of U.S. pharmaceutical companies abroad, have been pursuing bilateral free-trade agreements with developing countries that promise better investment and improved trade in exchange for legislation to protect U.S. intellectual property rights.

The agreements include restrictions on compulsory licenses, parallel importing,...
To view the full article, register now.